242 related articles for article (PubMed ID: 34443374)
1. Delivery of the VIVIT Peptide to Human Glioma Cells to Interfere with Calcineurin-NFAT Signaling.
Ellert-Miklaszewska A; Szymczyk A; Poleszak K; Kaminska B
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443374
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of a synthetic peptide inhibitor of nuclear factor of activated T cells as antirestenotic agent.
Yu H; Sliedregt-Bol K; Overkleeft H; van der Marel GA; van Berkel TJ; Biessen EA
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1531-7. PubMed ID: 16675727
[TBL] [Abstract][Full Text] [Related]
3. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A.
Aramburu J; Yaffe MB; López-Rodríguez C; Cantley LC; Hogan PG; Rao A
Science; 1999 Sep; 285(5436):2129-33. PubMed ID: 10497131
[TBL] [Abstract][Full Text] [Related]
4. Targeting of calcineurin to an NFAT-like docking site is required for the calcium-dependent activation of the background K+ channel, TRESK.
Czirják G; Enyedi P
J Biol Chem; 2006 May; 281(21):14677-82. PubMed ID: 16569637
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin activates pancreatic calcineurin-NFAT signaling in vitro and in vivo.
Gurda GT; Guo L; Lee SH; Molkentin JD; Williams JA
Mol Biol Cell; 2008 Jan; 19(1):198-206. PubMed ID: 17978097
[TBL] [Abstract][Full Text] [Related]
6. Blockade of Astrocytic Calcineurin/NFAT Signaling Helps to Normalize Hippocampal Synaptic Function and Plasticity in a Rat Model of Traumatic Brain Injury.
Furman JL; Sompol P; Kraner SD; Pleiss MM; Putman EJ; Dunkerson J; Mohmmad Abdul H; Roberts KN; Scheff SW; Norris CM
J Neurosci; 2016 Feb; 36(5):1502-15. PubMed ID: 26843634
[TBL] [Abstract][Full Text] [Related]
7. Nuclear presence of nuclear factor of activated T cells (NFAT) c3 and c4 is required for Toll-like receptor-activated innate inflammatory response of monocytes/macrophages.
Minematsu H; Shin MJ; Celil Aydemir AB; Kim KO; Nizami SA; Chung GJ; Lee FY
Cell Signal; 2011 Nov; 23(11):1785-93. PubMed ID: 21726630
[TBL] [Abstract][Full Text] [Related]
8. Selective modulation of nuclear factor of activated T-cell function in restenosis by a potent bipartite peptide inhibitor.
Yu H; Bot I; Sliedregt K; Xu X; Bot M; van Heiningen SH; van der Marel GA; Bennett MR; Overkleeft H; van Berkel TJ; Biessen EA
Circ Res; 2012 Jan; 110(2):200-10. PubMed ID: 22116820
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1beta-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity.
Sama MA; Mathis DM; Furman JL; Abdul HM; Artiushin IA; Kraner SD; Norris CM
J Biol Chem; 2008 Aug; 283(32):21953-64. PubMed ID: 18541537
[TBL] [Abstract][Full Text] [Related]
10. A novel peptide exerts potent immunosuppression by blocking the two-site interaction of NFAT with calcineurin.
Wang L; Cheng N; Wang P; Li J; Jia A; Li W; Zhang N; Yin Y; Tong L; Wei Q; Liu G; Li Z; Luo J
J Biol Chem; 2020 Feb; 295(9):2760-2770. PubMed ID: 31941790
[TBL] [Abstract][Full Text] [Related]
11. Neural activity regulates synaptic properties and dendritic structure in vivo through calcineurin/NFAT signaling.
Schwartz N; Schohl A; Ruthazer ES
Neuron; 2009 Jun; 62(5):655-69. PubMed ID: 19524525
[TBL] [Abstract][Full Text] [Related]
12. Structure of the calcineurin-NFAT complex: defining a T cell activation switch using solution NMR and crystal coordinates.
Takeuchi K; Roehrl MH; Sun ZY; Wagner G
Structure; 2007 May; 15(5):587-97. PubMed ID: 17502104
[TBL] [Abstract][Full Text] [Related]
13. Cell permeable NFAT inhibitory peptide Sim-2-VIVIT inhibits T-cell activation and alleviates allergic airway inflammation and hyper-responsiveness.
Choi JM; Sohn JH; Park TY; Park JW; Lee SK
Immunol Lett; 2012 Apr; 143(2):170-6. PubMed ID: 22342853
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of VIVIT, a selective peptide inhibitor of nuclear factor of activated T cells, in cardiovascular disorders.
Yu H; van Berkel TJ; Biessen EA
Cardiovasc Drug Rev; 2007; 25(2):175-87. PubMed ID: 17614939
[TBL] [Abstract][Full Text] [Related]
15. Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation.
Zawawi MS; Dharmapatni AA; Cantley MD; McHugh KP; Haynes DR; Crotti TN
Biochem Biophys Res Commun; 2012 Oct; 427(2):404-9. PubMed ID: 23000414
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting the calcineurin-NFAT (nuclear factor of activated T cells) signaling pathway with a regulator of calcineurin-derived peptide without affecting general calcineurin phosphatase activity.
Mulero MC; Aubareda A; Orzáez M; Messeguer J; Serrano-Candelas E; Martínez-Hoyer S; Messeguer A; Pérez-Payá E; Pérez-Riba M
J Biol Chem; 2009 Apr; 284(14):9394-401. PubMed ID: 19189965
[TBL] [Abstract][Full Text] [Related]
17. RCAN-11R peptide provides immunosuppression for fully mismatched islet allografts in mice.
Noguchi H; Sugimoto K; Miyagi-Shiohira C; Nakashima Y; Kobayashi N; Saitoh I; Watanabe M; Noguchi Y
Sci Rep; 2017 Jun; 7(1):3043. PubMed ID: 28596584
[TBL] [Abstract][Full Text] [Related]
18. A cell permeable peptide inhibitor of NFAT inhibits macrophage cytokine expression and ameliorates experimental colitis.
Elloumi HZ; Maharshak N; Rao KN; Kobayashi T; Ryu HS; Mühlbauer M; Li F; Jobin C; Plevy SE
PLoS One; 2012; 7(3):e34172. PubMed ID: 22479554
[TBL] [Abstract][Full Text] [Related]
19. Peptide 11R-VIVIT stimulates osteoblastogenesis through regulating the expression of nuclear factor of activated T cells cytoplasmic 1.
Li M; Wang X; Bian Z; Yao W; He Q; Tian F; Zhang J; Zhu L
Cell Mol Biol (Noisy-le-grand); 2017 Apr; 63(4):46-52. PubMed ID: 28478803
[TBL] [Abstract][Full Text] [Related]
20. PTD-mediated intracellular delivery of mutant NFAT minimum DNA binding domain inhibited the proliferation of T cells.
Liu X; Zhao Q; Peng X; Xia S; Shen W; Zong Y; Cheng J; Wu W; Zhang M; Du F; Xu W; Qian H; Shao Q
Int Immunopharmacol; 2014 Mar; 19(1):110-8. PubMed ID: 24440534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
